Akihiko Kawahara Selected Research

Ligands

2/2024	Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma.
1/2021	CD8+ T Cell Infiltration Predicts Chemoradiosensitivity in Nasopharyngeal or Oropharyngeal Cancer.
6/2019	Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients.
11/2018	Radiological Features of Programmed Cell Death-Ligand 2-positive Lung Adenocarcinoma: A Single-institution Retrospective Study.
10/2018	PD-L2 Expression as a Potential Predictive Biomarker for the Response to Anti-PD-1 Drugs in Patients with Non-small Cell Lung Cancer.
10/2018	Prognostic Impact of PD-L2 Expression and Association with PD-L1 in Patients with Small-cell Lung Cancer.
11/2017	Association between PD-L1 expression combined with tumor-infiltrating lymphocytes and the prognosis of patients with advanced hypopharyngeal squamous cell carcinoma.
9/2017	Programmed cell death-ligand 1 expression and immunoscore in stage II and III non-small cell lung cancer patients receiving adjuvant chemotherapy.
3/2016	Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
3/2015	Significance of programmed cell death-ligand 1 expression and its association with survival in patients with small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihiko Kawahara Research Topics

Disease

87	Neoplasms (Cancer) 11/2023 - 11/2003
37	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 06/2009
15	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2009
9	Carcinoma (Carcinomatosis) 11/2023 - 11/2014
9	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2008
9	Breast Neoplasms (Breast Cancer) 01/2020 - 03/2008
8	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 07/2011
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 04/2012
5	Stomach Neoplasms (Stomach Cancer) 07/2020 - 08/2010
5	Adenocarcinoma of Lung 06/2019 - 02/2014
4	Squamous Cell Carcinoma of Head and Neck 02/2024 - 01/2020
4	Pancreatic Neoplasms (Pancreatic Cancer) 06/2023 - 06/2006
4	Adenocarcinoma 05/2021 - 07/2011
3	Insulinoma 09/2019 - 03/2018
3	Pleural Effusion (Pleural Effusions) 09/2019 - 02/2014
2	Cachexia 10/2023 - 01/2023
2	Hypoxia (Hypoxemia) 02/2023 - 04/2013
2	Fatigue 01/2023 - 03/2013
2	Esophageal Squamous Cell Carcinoma 08/2021 - 10/2016
2	Triple Negative Breast Neoplasms 01/2020 - 07/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2018 - 08/2015
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2018 - 03/2018
2	Melanoma (Melanoma, Malignant) 11/2017 - 06/2009
2	Lymphatic Metastasis 01/2014 - 05/2012
2	Carcinogenesis 06/2012 - 07/2011
2	Papillary Thyroid Cancer 10/2011 - 08/2011
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2023
1	Disease Progression 01/2023
1	Weight Gain 01/2023
1	Dysgeusia (Parageusia) 01/2023
1	Dizziness (Lightheadedness) 01/2023

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2006
15	ErbB Receptors (EGF Receptor)IBA 09/2017 - 09/2009
14	Biomarkers (Surrogate Marker)IBA 10/2023 - 09/2009
10	LigandsIBA 02/2024 - 03/2015
9	Immune Checkpoint InhibitorsIBA 10/2023 - 11/2017
9	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 04/2011
8	B7-H1 AntigenIBA 02/2023 - 01/2017
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 06/2009
8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2018 - 08/2011
8	Peptides (Polypeptides)IBA 05/2016 - 04/2012
7	Fluorine-18IBA 01/2020 - 07/2010
7	DNA (Deoxyribonucleic Acid)IBA 09/2018 - 06/2010
7	Gefitinib (Iressa)FDA Link 01/2014 - 06/2010
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017 - 06/2010
5	AntibodiesIBA 11/2014 - 06/2010
4	SynaptophysinIBA 09/2019 - 08/2012
4	Transcription Factors (Transcription Factor)IBA 01/2017 - 02/2013
4	Monoclonal AntibodiesIBA 10/2016 - 11/2014
4	MucinsIBA 11/2014 - 04/2012
4	Phosphotransferases (Kinase)IBA 08/2014 - 06/2009
3	Cell-Free Nucleic AcidsIBA 06/2023 - 10/2015
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 06/2009
3	Anaplastic Lymphoma KinaseIBA 09/2018 - 11/2014
3	VimentinIBA 02/2018 - 11/2003
3	Cadherins (E-Cadherin)IBA 02/2018 - 06/2012
3	ChromatinIBA 02/2018 - 07/2008
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2014 - 07/2010
3	Tyrosine Kinase InhibitorsIBA 01/2014 - 01/2012
3	matrigelIBA 01/2014 - 06/2006
3	CateninsIBA 07/2012 - 07/2011
2	S100 Proteins (S 100 Protein)IBA 11/2023 - 06/2011
2	Capsules (Microcapsules)IBA 11/2023 - 01/2016
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 02/2023 - 07/2013
2	entrectinibIBA 01/2023 - 01/2022
2	Carcinoembryonic AntigenIBA 08/2022 - 11/2003
2	osimertinibIBA 01/2022 - 09/2017
2	PlatinumIBA 01/2021 - 01/2013
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2020 - 01/2017
2	Keratins (Keratin)IBA 05/2018 - 04/2018
2	Estrogen Receptor alphaIBA 01/2018 - 03/2008
2	HLA Antigens (Human Leukocyte Antigens)IBA 11/2017 - 10/2013
2	AfatinibIBA 09/2017 - 08/2014
2	Cancer VaccinesIBA 05/2016 - 10/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2015 - 05/2015
2	Phenobarbital (Luminal)FDA Link 07/2015 - 11/2002
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2014 - 06/2009
2	Docetaxel (Taxotere)FDA Link 11/2013 - 08/2009
2	CytokinesIBA 08/2013 - 04/2011
2	Indicators and Reagents (Reagents)IBA 04/2013 - 05/2012
2	Insulin (Novolin)FDA Link 02/2013 - 07/2011
2	locked nucleic acidIBA 01/2013 - 10/2011
2	Peptide Nucleic AcidsIBA 01/2013 - 10/2011
2	EnzymesIBA 06/2012 - 08/2010
2	Claudin-1IBA 06/2012 - 07/2011
2	Small Interfering RNA (siRNA)IBA 05/2012 - 03/2008
2	TubulinIBA 08/2009 - 06/2009
1	GhrelinIBA 10/2023
1	OsteopontinIBA 10/2023
1	C-Reactive ProteinIBA 10/2023

Therapy/Procedure

14	Therapeutics 02/2023 - 08/2009
11	Drug Therapy (Chemotherapy) 01/2023 - 06/2009
9	Immunotherapy 10/2023 - 04/2012
4	Radiotherapy 02/2023 - 05/2012
3	Aftercare (After-Treatment) 01/2019 - 10/2015
2	Chemoradiotherapy 01/2021 - 03/2016
2	Gastrectomy 07/2020 - 04/2013
2	Neoadjuvant Therapy 11/2017 - 11/2013
1	Brachytherapy 02/2023
1	Precision Medicine 01/2023